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1 The abbreviations used are: P450, cytochrome P450; Cd, cindoxin; CPR, cytochrome P450 
reductase; P450
cin, CYP176A1; P450cam, CYP101; P450terp, CYP108; P450BioI, CYP107H; RZ, 
(A415nm/A280nm) used when determining the purity of P450 samples (> is better); ORF, open reading 
frame; KD, dissociation constant; IPTG, isopropyl-β-D-thiogalactopyranoside; PMSF, 
phenylmethylsulfonyl fluoride; DTT, DL-Dithiotheitol; Tris, tris(hydroxymethyl)aminomethane; 
EDTA, ethylenediaminetetraacetic acid; Amp, ampicillin; TB, Terrific broth; cineole, 1,8-
cineole.  Degenerate DNA code used: R=A or G; K=G or T; H=A, C or T; M=A or C; N=A, T, C 
or G. 
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Abstract: Cytochromes P450 are members of a superfamily of hemoproteins involved in the 
oxidative metabolism of various physiologic and xenobiotic compounds in eukaryotes and 
prokarayotes.  Studies on bacterial P450s, particularly those involved in monoterpene oxidation, 
have provided an intergral contribution to our understanding of these proteins, away from the 
problems encountered with eukaryotic forms. We report here a novel cytochrome P450 (P450cin, 
CYP176A1) purified from a strain of Citrobacter braakii which is capable of using cineole 1 as 
its sole source of carbon and energy.  This enzyme has been purified to homogeneity and the 
amino acid sequences of three tryptic peptides determined.  Using this information, a PCR-based 
cloning strategy was developed that allowed the isolation of a 4kb DNA fragment containing the 
cytochrome P450cin gene (cinA).  Sequencing revealed three open reading frames which were 
identified on the basis of sequence homology as a cytochrome P450, an NADPH dependent 
flavodoxin/ferrodoxin reductase and a flavodoxin.  This arrangement suggests that P450cin may 
be the first isolated P450 to use a flavodoxin as its natural redox partner.  Sequencing also 
identified the unprecedented substitution of a highly conserved catalytically important, active site 
threonine with an asparagine residue.  The P450 gene was subcloned and heterologously 
expressed in E. coli at approximately 2000 nmol/l of original culture and purification was 
achieved by standard protocols. Postulating the native E. coli flavodoxin/flavodoxin reductase 
system might mimic the natural redox partners of P450
cin, it was expressed in E. coli in the 
presence of cineole 1.  A product was formed in vivo that was tentatively identified by GCMS as 
2-hydroxycineole 2.  Examination of P450cin by UV/visible spectroscopy revealed typical spectra 
characteristic of P450s, a high affinity for cineole 1 (KD = 0.7 µM), and a large spin state change 
of the heme iron associated with binding of cineole 1. These facts support the hypothesis that 
cineole 1 is the natural substrate for this enzyme and that P450cin catalyses the initial 
monooxygenation of cineole 1 biodegradation.  This constitutes the first characterization of an 
enzyme involved in this pathway. 
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INTRODUCTION 
The cytochrome P450s (P450s) are a superfamily of oxidative hemoproteins (1,2) that 
carry out an enormous variety of oxidative transformations.  These range from simple alkene 
epoxidation and heteroatom oxidation all the way through oxygen insertion into unactivated C-H 
bonds and C-C bond cleavage (3).  P450s are broadly categorized as either soluble, e.g., most 
bacterial P450s, or as membrane bound/microsomal monooxygenases, e.g., most eukaryotic 
P450s.  All P450s, however, contain a prosthetic heme group that is ligated to the protein 
backbone by a cysteinyl sulfur coordinated to the heme iron.  It is this heme-thiolate moiety that 
is responsible for much of the chemistry carried out by these enzymes.  The typical reaction 
catalyzed by a P450 is given by the following equation: 
RH + NAD(P)H + H+ + O2 -> ROH + NAD(P)+ + H2O 
The exact mechanism of the oxidation reaction is still the subject of much debate, despite an 
enormous amount of work (3,4).  The electrons derived from the nicotinamide cofactors are 
generally transferred to the P450 one at a time by auxiliary redox protein(s) that are characteristic 
of the origin of the enzymes.  Thus, bacterial P450s generally employ an FAD dependent 
ferrodoxin reductase and an iron sulfur protein to mediate this transfer while microsomal P450s 
employ a single protein that contains both an FAD and an FMN domain. 
Investigations of bacterial P450s have provided much of our current understanding of 
P450 mechanism and structure.  This is particularly true of P450
cam
 isolated from Pseudomonas 
putida, in part because it was the first P450 available in relatively large amounts (5).  However, 
some features of P450
cam
 appear to be unique to this enzyme, e.g., a potassium binding site (6), 
and not typical of this enzyme class.  P450
cam
 still remains the most studied of all P450s and one 
of the few bacterial enzymes of this family that has been heterologously expressed with its redox 
partners as a catalytically active system (7).  It is a biodegradative enzyme that catalyses the 
conversion of camphor to 5-exo-hydroxycamphor, which initiates a cascade of biodegradative 
reactions, that allow P. putida to live on camphor as its sole source of carbon and energy (8).  
P450
cam
 and others involved in such pathways e.g. P450lin (9), P450terp (10) are generally 
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characterized by high substrate specificity and high rates of turnover.  As such, they make 
attractive starting points for attempting to design biocatalysts that can carry out synthetically 
useful oxidative transformations.  We wished to isolate a new bacterial biodegradative P450 
system that could be i) used for comparison with P450
cam
; ii) heterologously expressed as a 
catalytically active system and iii) used as the basis for constructing libraries of P450s that would 
be explored for their ability to catalyze useful oxidative transformations.  Such a P450 system 
was implicated in the bacterial utilization of 1,8-cineole (cineole, 1, Scheme 1).   
Eucalypt trees produce a mixture of nearly 50 hydrocarbons termed the “essential oil” 
which contains extremely high concentrations of the monoterpene cineole 1. The role of cineole 
1 is somewhat unclear, though it is believed to be involved in a number of functions including 
defense against herbivores (11,12) and pathogens (13), attracting pollinators and fruit-dispersing 
animals (14) and/or as an allelopathic agent (15,16). The Australian eucalypt population 
collectively produces and releases an estimated 500,000 tons of cineole 1 into the environment 
annually (17).  Studies indicate that the major part of the released cineole 1 is rapidly removed by 
microbial oxidation (18), with lesser quantities consumed by native wildlife (19) and bushfires. 
In 1979 R. MacRae isolated a soil microorganism identified as P. flava, which could 
utilize cineole 1 as it sole source of carbon and energy (18) and oxidized derivatives of cineole 1 
were identified in the growth medium.  Subsequently, Trudgill et al identified a Rhodococcus 
species also capable of using cineole 1 as its sole carbon source, and similarly identified 
oxygenated cineole derivatives (20). Interestingly, it was found that the initial oxidation of 
cineole 1 by the two organisms produced enantiomeric forms of 2-hydroxycineole 2. A metabolic 
pathway for the catabolism of cineole 1 in Rhodococcus sp.C1 was proposed, based on the 
isolated metabolites (Scheme 1).  Thus, cineole 1 is initially oxidized to 2-hydroxycineole 2 by a 
monooxygenase and further transformations lead to a highly functionalized hydroxyketo acid 3 
that may spontaneously form the isolated dihydrofuranone 4 or be incorporated into central 
metabolic pathways. 
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Despite the relatively large amount of information concerning the chemistry of the 
cineole 1 biodegradative pathway, nothing was known about the enzymes involved.  Early 
attempts at isolating the proposed monooxygenase that catalyses cineole 1 oxidation failed (21).  
Several lines of evidence suggested, however, that the monooxygenase might be a P450.  The 
biodegradative utilization of a number of monoterpenes, including camphor, linalool and 
terpineol have all been shown to be initiated by oxidations catalyzed by P450s (21).  
Additionally, CYP3A4 was recently identified as being the main P450 isoform responsible for 
cineole 1 metabolism in humans, with the primary product, 2-hydroxycineole 2, being the same 
as the one implicated in bacterial biodegradation (22).  Finally, the relative scarcity of other 
enzymes e.g. non-heme iron oxygenases capable of carrying out such an oxidation also suggested 
a P450 would be involved.   
We thus set out to isolate and characterize a monooxygenase system involved in the 
bacterial utilization of cineole 1.  Reported here is the isolation, over-expression and purification 
of a P450, P450
cin, believed to be responsible for cineole 1 oxidation.  In addition, the sequences 
of two genes that may encode the required redox partners for P450cin are described along with 
preliminary characterization of the P450 that supports its involvement in the biodegradation of 
cineole 1.    
 
[INSERT SCHEME 1 HERE] 
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EXPERIMENTAL PROCEDURES 
 Materials-Yeast extract and Bacto-tryptone were obtained from Becton Dickinson and 
Co. (Cockeysville, MD).  Reagent grade 1,8-cineole was obtained from Aldrich.  Sodium 
dithionite (sodium hydrosulfite) was purchased from Aldrich Chemical Co.  Inc. (Milwaukee, 
WI).  Nylon hybridization transfer membranes (GeneScreen Plus) were obtained from NEN 
Life Science Products (Boston, MA).  All other chemicals used were purchased from commercial 
sources and were of the highest grade generally available.  The restriction enzymes and 
polynucleotide kinase were obtained from New England Biolabs, Inc. (Beverly MA), and 
Boehringer Mannheim Corp. Biochemical Products (Indianapolis, IN) based on availability.  
Terminal deoxynucleotidyl transferase was obtained from Promega Corporation (Madison, WI).  
Escherichia coli strain DH5αF’ φ80dlacZ∆M15 ∆(lacZYA-argF) U169 deoR recA1 endA1 
hsdR17(rk-, mk+) phoA supE44 λ- thi-1 gyrA96 relA1, was obtained as frozen competent cells, 
and from Life Technologies. Inc. (Gaithersburg. MD).  Sonication was achieved using a Branson 
Sonicator set to 50% duty cycle. 
Isolation of the microorganism- Soil samples were collected from several sites beneath 
eucalypt trees within a small eucalypt forest at the University of California San Francisco, USA.  
A dirt/water slurry prepared from each sample was transferred to minimal medium (23) and 
bacteria selected for an ability to use 1,8-cineole as the sole carbon source.  Following several 
rounds of serial culturing (1 into 50 dilutions) at 30°C, the cell culture was spread onto minimal 
medium plates (1.5% agar plates) with 0.5 g of cineole in the lid, yielding a single pure strain 
according to the protocol of Peterson et al. (23).  The strain was propagated in 10-15 ml of 
minimal medium with 20µl of 1,8-cineole at 30 °C.   
Tryptic Digest of P450
cin - Internal amino acid sequence for P450cin was obtained from 
tryptic peptides of P450cin.  These were purified by microbore HPLC and sequenced using 
automated Edman degradation protein sequencer.  This data was used in concert with that 
obtained via MALDI mass spectrometry to yield the sequence of three fragments (Table I).   
[INSERT TABLE 1 HERE] 
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 Preparation of Whole Cell DNA– Cells were grown on minimal medium (23) with 1,8-
cineole as the sole carbon source at 30 °C.  Whole cell DNA was prepared according to Peterson 
(24). 
Generation of an oligonucleotide probe to cytochrome P450cin- A 92 bp PCR product 
was amplified from whole cell DNA (C. braakii) using degenerate primers (5’-ATAT GAATTC 
TGG GCN ATM CAN CAH GT-3’ and 5’-TATC GGATCC CK NGC RTG NGC NAC-3’) 
designed based upon five amino acids at either end of Fragment 1 (Fig. 1).  PCR was performed 
according to the following protocol; 94 °C 3 min; [94 °C 1 min, ramp to 37 °C over 2 min, 72 °C 
1 min] x 5 cycles; [94 °C 1 min, 55 °C 1 min, 72 °C 1 min] x 25 cycles; 72 °C 10 min; 4 °C.  
The product was treated with BamHI and EcoRI, and cloned into similarly cut pCRII 
(Invitrogen).  The insert sequenced on an automated sequencer using M13 forward and reverse 
primers, confirming the central non-degenerate 42 bp coded for the same fourteen amino acids 
seen in Fragment 1 (Table 1).  The 92 bp insert was labeled with [α-32P] dCTP using terminal 
deoxynucleotidyltransfease (25) and denatured at 100 °C prior to use in subsequent 
hybridizations. 
[INSERT FIGURE 1 HERE] 
Library Construction and Screening – DNA isolated from C. braakii was digested with a 
bank of restriction enzymes (KpnI, PstI, SalI, PstI/HindIII, SalI/HindIII, XhoI) and separated by 
electrophoresis on an agarose gel (0.7% w/v, 0.5 x TBE).   The DNA was transferred to a nylon 
membrane (GeneScreen Plus NEN) by capillary transfer, dried and probed with labeled 
oligonucleotide (26).  Autoradiography revealed bands of suitable size in PstI (4 kb) and SalI (3 
kb) digests.  These latter digests were repeated, separated by electrophoresis and the bands of 
appropriate size recovered by gel extraction. 
The recovered DNA fragments were ligated into PstI or SalI digested pUC19 and 
transformed individually into library efficiency DH5α cells producing PstI and SalI libraries. 
Approximately 4,000-5,000 recombinant cells for each fragment were plated onto 2 x YT plates 
containing ampicillin (50 µg/ml) and incubated overnight.  Colonies were lifted onto nylon 
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membranes and their DNA fixed by successive treatments with 0.5 M NaOH, 1.5 M NaCl (4 
min), 1 M TrisHCl, pH 7.4, 1.5 M NaCl (4 min) and 50 mM TrisHCl, pH 8.5, 50 mM EDTA, 
100 mM NaCl, 1% sodium laurylsarcosine and 250 µg/ml proteinase K (20 min).  Membranes 
were dried and the DNA crosslinked via UV irradiation. The membranes were screened by 
hybridization using the 92 bp oligonucleotide probe, labeled with 32P as described above.  
Putative positive clones were picked from the original plates, grown overnight in 2 x YT medium 
containing ampicillin (50 µg/ml).  The identities of the clones were confirmed by restriction 
analysis and southern hybridization.  A positive PstI (4 kb) clone (designated pC1) was 
identified.  Restriction analysis of pC1 revealed the SalI (3 kb) fragment (cloned as pC2) was 
contained entirely within the Pst (4 kb) fragment and so its isolation was not pursued further.  To 
gain further sequence information, probes generated by the random primer method (27) using the 
pC1 insert as template were used to probe an EcoRI/SphI digest of C. braakii DNA.  An SphI 
(2.9 kb) and EcoRI/SphI (5.7 kb) fragment were isolated and cloned into pUC19 to give pC3 and 
pC4 respectively (Fig. 2).   
Sequencing- Careful restriction analysis of clones pC1 and pC4 identified a series of 
small internal fragments that were subcloned and sequenced using the M13 forward and reverse 
primers.  Gaps remaining in the sequence were filled by employing suitable synthetic primers.  
Sequencing data were analyzed using the BLAST algorithm (NCBI) and three open reading 
frames (cinA, cinB and cinC) were identified which were sequenced completely in both 
directions.†  
Cloning of P450cin – Primers were designed to either end of cinA containing suitable 
terminal restriction sites (EcoRI and NdeI for the N-terminal primer – 5’-CC GATTC CATATG 
AC TGC GAC AGT CGC-3’, and XbaI and EcoRI for the C-terminal primer –5’-CC 
GAATTCTAGA GGA GCT TGC TCA TTC CG-3’).  A PCR experiment was performed with 
pC1 as template DNA according to the following parameters:  94 °C for 3 min; 30 cycles of 94 
°C for 45 sec, 52 °C for 1 min, 72 °C for 1 min 30 sec.  The single 1.2 kb product was digested 
                                                 
†
 Sequence data has been submitted to Genebank: Acession No. AF456128 
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with EcoRI and inserted into the EcoRI site of pUCPKS (28).  To ensure no errors had been 
introduced by PCR the majority of the internal sequence was replaced according to the following 
procedure: the clone was cut with NcoI, treated with DNA polymerase (Klenow) in a fill-in 
reaction and religated to produce a selectable P450cin mutant.  Both the mutant and pC1 were 
digested with PpuMI/SphI.  The wild-type 1.2 kb PpuMI/SphI insert from pC1 was used to 
replace the mutant insert in pUCPKS.   An NcoI digest was performed to confirm the wild-type 
fragment had indeed been inserted, and sequencing (using M13 forward and reverse primers) 
confirmed no PCR errors were incorporated into either terminus of cinA.  An EcoRI fragment 
was excised from pUCPKS-cinA and cloned into pUC19.  This
 
allowed convenient excision with 
NdeI/HindIII for insertion into pCW, producing pCW-P450cin. 
Purification of recombinant Cytochrome P450cin – E. coli (DH5α) cells freshly 
transformed with expression vector pCW-P450cin were cultured overnight in 2 ml of 2 x YT/Amp 
(50 µg/ml ampicillin) medium. This was used to inoculate four 2.8 L fernbach flasks containing 
1 L of TB/Amp (50 µg/ml ampicillin) medium.  The flasks were incubated at 37 °C (4.5 h 
approx.) until an OD600 of 0.6 was attained.  The cells were then induced with IPTG (1 mM) and 
incubated at 27 °C for 18 h. Cells were harvested via centrifugation (6000g) for 20 min at 4 °C 
and then resuspended in 80 ml of 50 mM Tris.HCl pH 7.4, 50 mM KCl, 1 mM EDTA, 0.1 mM 
PMSF, 0.5 mM DTT, cineole (750 µM).  An indication of purity of various cytochrome P450cin 
preparations was obtained by measuring the ratio of the absorbance at 415 nm to that at 280 nm.  
Lysis was carried out by adding lysozyme (40 mg) and stirring the suspension for 1 hr at 4 °C, 
followed by sonication on ice (6 x 1 min intervals, 50% output).  The lysate was centrifuged 
(15000g) for 1 hr to remove cellular debris.  The supernatant was loaded onto a DEAE ion 
exchange column which was then washed with 50 mM Tris.HCl pH 7.4, 50 mM KCl, 0.5 mM 
DTT (Buffer A).  Protein was then eluted from the column by running a KCl gradient (50-500 
mM KCl) in Buffer A.  Fractions containing P450cin were detected by its characteristic soret 
absorbance at 415 nm and were combined. P450cin eluted at approximately 180 mM KCl.  Pooled 
fractions were concentrated in an Amicon ultrafiltration cell containing a YM-30 membrane.  
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The concentrate was then separated on an S-300 Sephacryl gel filtration column using Buffer A.  
P450cin containing fractions were pooled, concentrated to approximately 3-5mls using an Amicon 
ultrafiltration cell (YM-30 membrane), then loaded onto a hydroxyapatite column equilibrated 
with 5 mM KH2PO4 pH 7.2. A phosphate gradient (5-300 mM KH2PO4) was run (0.5 ml/min). 
P450
 cin eluted at ~120 mM KH2PO4.  Fractions with an R/Z of >1.2 were combined. The 
cytochrome P450 content was determined from the difference spectrum between samples which 
had been reduced with sodium dithionite and carbon monoxide saturated versus a sodium 
dithionite treated reference sample using an ε450 of 125 mM-1cm-1.  Purified protein was snap 
frozen in liquid nitrogen and stored at –80 °C.  The procedure produced 42 mg of P450
cin per liter 
of culture. 
Calculation of Molar Extinction Coefficients (ε) for P450
cin – A dilute solution of P450cin 
was prepared and characterized by UV in the presence of cineole.  The protoheme content of the 
solution was determined as the pyridine haemochromogen, which was prepared as follows.  
Pyridine (80µl) was added to the P450
cin solution (272µl) and gently mixed.  10% SDS (40ul) 
was added and the volume brought to 400µl.  The solution was then divided equally between two 
cuvettes (reference and sample).  Sodium dithionite (0.5-1mg) was added to the sample cuvette 
and the difference spectra recorded on a dual beam spectrophotometer. The absorbance at 556.5 
nm (A556.5nm-A570nm) was measured and the haemochromogen content estimated using an ε value of 
33.2 mM-1 (29).  The following molar extinction coefficients were calculated for P450
cin: Ferric, 
substrate bound, ε392 = 132 mM
-1
cm
-1; Ferric, substrate free, ε415 = 150 mM
-1
cm
-1; Ferrous, 
(substrate present),
 
ε411 =  106 mM
-1
cm
-1
. 
 In vivo oxidation of cineole by P450
cin – E. coli (DH5α) cells freshly transformed with 
expression vector pCW-P450cin were cultured overnight in 2 ml of 2 x YT/Amp medium. This 
was used to inoculate 500ml of TB/Amp (100 µg/ml ampicillin) medium.  The flasks were 
incubated at 37 °C (4.5 h approx.) until an OD600 of 0.6 was attained.  The cells were then 
induced with IPTG (1 mM) and cineole (250 µl) was added.   The culture was incubated at 27 °C 
for 36 h. Cells were removed via centrifugation (6000g) for 20 min at 4 °C and the supernatant 
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extracted with ethyl acetate (2 x 100 ml).  The combined organic extracts were dried over 
magnesium sulfate and concentrated in vacuo and the residue analyzed by GCMS (BP-5 column 
(30 m x 0.25mm); Temperature program: 60°C, 2min; 16°C min-1 to 250 °C).  A peak was 
observed with a mass spectrum consistent with that reported for 2-hydroxycineole 2 (20) [GCMS 
m/z: 170 (M+., 6%), 155 (M-CH3, 1), 126 (37), 108 (70), 93(34), 71 (59), 69 (37), 43 (100)]. 
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RESULTS 
Isolation of Citrobacter braakii – A microorganism capable of utilizing 1,8-cineole 1` as 
its sole carbon source was isolated through culture enrichment (23) of bacteria from the cineole 1 
enriched soils beneath eucalypt trees.  The procedure yielded a pure strain identified using the 
Biolog Identification System (Biolog, Inc., Hayward, Calif.) (30) as C. braakii.  This strain grew 
best at room temperature on a variety of nutrient rich media. However, use of such media 
resulted in loss of the ability to grow on cineole 1 as a sole carbon source, and thus the organism 
was generally maintained on minimal medium (23) in the presence of cineole1.  Examination of 
CO difference spectra of cell lysates from these cultures indicated that a P450 was present, albeit 
at low concentrations.   
Purification of P450cin from C. braakii-A P450 was purified from a large scale culture of 
C. braakii grown on minimal medium in the presence of cineole 1.  The purification protocol 
used was based on those published for P450
cam
, P450terp and P450BioI ((9,10,31)).  A refined version 
of this protocol is currently used for purification of recombinant P450cin (vide infra).  The 
procedure yielded purified protein with a peak fraction possessing an R/Z (A415/A280) of ~1.28.  
The protein isolated was clearly a P450 by CO difference spectroscopy and had a molecular 
weight of approximately 45 kDa by SDS PAGE analysis.  Importantly, the heme Soret 
absorbance at 415 nm shifted to 392 nm in the presence of cineole 1. This is characteristic of the 
spin state change of the heme iron (low to high spin) seen upon binding of substrate to a P450 
and strongly suggested that the isolated P450cin was involved in cineole 1 metabolism.  
Tryptic Digestion and Sequencing of Protein Fragments - N-terminal sequencing of 
P450cin (purified from C. braakii) using automated Edman degradation failed to produce useful 
data, presumably due to N-terminal blocking.  However, tryptic digestion of the protein followed 
by HPLC purification of the resultant fragments gave several peptides amenable to Edman 
degradation.  A combination of automated Edman degradation sequencing and mass 
spectrometry yielded the sequences of three fragments which are shown in Table 1. Fragments 1 
and 2 are clearly related, differing only in the identity of the first amino acid.  However, as their 
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sequences were independently obtained we were confident of their reliability and this sequence 
was chosen as the basis upon which to design oligonucleotides for use in isolation of the gene 
encoding P450cin. Fragment 3 was not useful for probe design due to the preponderance of amino 
acids with highly degenerate codons.  We chose to amplify a larger segment of the P450 gene by 
PCR in order to generate a better probe, rather than simply employ short degenerate 
oligonucleotides.  Thus, degenerate primers were designed to either end of coding sequence for 
Fragment 1 and were chosen to minimize their inherent degeneracy (Fig 1).  These were used in 
a PCR experiment with genomic DNA from C. braakii as template.  The product from this PCR 
was sequenced and shown to encode the peptide Fragment 1, providing the key, unique 92 bp 
probe for P450cin. 
Southern Hybridization-Probing a series of restriction enzyme digests of C. braakii 
genomic DNA with the 92 bp probe labeled with 32P by reaction with [γ-32P]-ATP in the 
presence of polynucleotide kinase failed to yield useable results.  Believing that sensitivity was 
the source of our problems we chose to label the probe with [α-32P]-dCTP in the presence of 
terminal deoxynucleotidyl transferase.  TdT is known to transfer up to 30 nucleotides to the 3’ 
end of single stranded DNA, which we hoped would result in an order of magnitude increase in 
the specific activity, and thus sensitivity, of the probe.  With dCTP labeled oligonucleotide, 
southern hybridization experiments led to the isolation of a 4 kB PstI fragment that was cloned 
into pUC19 to give pC1.   Initial results revealed that this PstI fragment did not contain a stop 
codon for the final gene in the putative operon (vide infra).  Thus, random priming using pC1 
insert was employed to isolate two further genomic fragments which were cloned into pUC19 as 
pC3 and pC4, such that the entire operon containing P450cin could be sequenced (Fig 2).   
Operon Analysis.  Sequencing of the above DNA fragments revealed a putative operon 
consisting of three open reading frames with overlapping stop and start codons (Fig. 2).  All orf’s 
were analyzed using the BLAST algorithm (32) and the Genbank database.  The first orf (cinA) 
encoded a 405 amino acid protein with a predicted molecular weight of 45 kDa.  Homology 
analysis indicated that it was clearly a P450, being similar to a number of bacterial P450s (Table 
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2), including P450
cam
 (27% identity, 46% similarity) but different enough to be classified as the 
sole member of a new P450 family CYP176A1 (2).  All of the peptide fragments that had been 
characterized from the tryptic digest of the isolated P450 were encoded by this gene.   
The two other orf’s (cinB and cinC) appeared to encode the expected redox partners for a 
catalytically functional P450 system.  The second orf (cinB) encoded a 49 kDa, 452 amino acid 
protein that was apparently an NADPH dependent ferrodoxin reductase on the basis of sequence 
homology (Table 2).  The final gene (cinC) encoded a protein (16 kDa, 155 amino acids) that 
was most similar to the FMN containing domain of cytochrome P450 reductase (Table 2).  The 
participation of a dedicated flavodoxin as a P450 redox partner has not previously been described 
but E. coli flavodoxin has been reported to provide an unnatural redox partner for a variety of 
heterologously expressed cytochromes (33).  
[INSERT TABLE 2 HERE] 
Subcloning and Expression of P450cin.  A PCR based approach was used to clone the 
cinA gene into the expression vector pCWori (34).  Expression of the encoded protein after 
induction with IPTG was monitored by SDS PAGE and CO difference spectroscopy of cell 
lysates.  It was found that while polypeptide production occurred at temperatures from 25 to 37 
°C, P450 holoprotein was only observed when the growth temperature was below 28 °C.  CO 
difference spectroscopy indicated that P450 was produced at concentrations of approximately 
2000 nmol/l of original culture.  Characterization of the purified protein by N-terminal 
sequencing and electrospray mass spectrometry gave similar results.  Both techniques clearly 
identified the protein as P450cin and indicated that some degree of N terminal processing of the 
protein had occurred.  The degree of processing varied between different preparations, with some 
having the major species present derived from loss of the N-terminal methionine, while others 
had the predominant protein derived from loss of the first six amino acids of the predicted 
sequence.   
In vivo oxidation of cineole by P450
cin – When P450cin was expressed in E. coli in the 
presence of cineole 1 a metabolite was produced with mass spectral characteristics consistent 
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with that of 2-hydroxycineole 2.  This compound was not produced when E. coli not expressing 
P450
cin was grown in the presence of cineole 1.  This result strongly supports the hypothesis that 
P450
cin catalyses the first monooxgenation in the biodegradation of cineole 1.   
 Spectral Characteristics of Cytochrome P450cin - The protein was first examined by 
UV/visible spectroscopy (Fig. 3) which revealed the typical characteristics of a bacterial P450: a 
heme soret at 415 nm in the absence of substrate which shifted to 392 nm upon the addition of 
cineole 1.  This spectral change is correlated with a change in the heme iron from low to high 
spin and is associated with the binding of substrate to bacterial P450s and as such was the first 
evidence that cineole 1 was indeed the natural substrate of this enzyme.  Reduction of the protein 
with dithionite and treatment with CO resulted in the formation of a CO complex with the typical 
449 nm absorbance of a P450.   
[INSERT FIGURE 3 HERE] 
 1,8-Cineole Binding by Cytochrome P450cin –The addition of 1,8-cineole 1 to the 
substrate free form of the enzyme results in a decrease in absorbance at 415 and 568 nm and an 
increase in absorbance at 392 and 643 nm, indicating the conversion of low-spin hemoprotein to 
the high-spin form (35). Difference spectroscopy (Fig. 4) was used to calculate a dissociation 
constant for the enzyme-substrate complex (KD) by adding cineole 1 to a solution of P450cin and 
monitoring the absorbance at 415 and 392 nm. The difference (measured as A392-A415) was 
plotted against the cineole 1 concentration to produce a substrate-binding curve (Fig. 4) from 
which a KD value of 0.7 µM was determined using the following equation: 
[S]TOT = (KD ∆A)/(∆Amax – ∆A) + ∆A/ε 
 where: [S]TOT is the concentration of added ligand, KD is the dissociation constant of ligand-
P450 complex, ∆A is the measured peak to trough difference in absorbance between 415nm and 
392 nm, ∆Amax is the maximal ∆A value and ε is the molar absorptivity constant for the 
difference in absorbance at 415 nm and 392 nm of the high and low spin forms of the P450 i.e. 
((ε415LS- ε415HS) + (ε392HS- ε392LS)).  This calculation was made with the following 
assumptions (1) [S]TOT = [S]FREE + [ES] and (2) [E]TOT = [E]FREE +[ES] where [ES] is the 
 at UQ Library on November 10, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
17 
concentration of the P450-ligand complex, [S]TOT and [S]FREE are the total and free ligand 
concentration respectively and [E]TOT and [E]FREE are the total and free P450 concentration 
respectively.  Because of the high affinity of the enzyme for its ligand, the assumption that [ES] 
<< [S]TOT, which would greatly simplify the calculation, is not valid.   
[INSERT FIGURE 4 HERE] 
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 DISCUSSION 
Prior to the beginning of this work, much was known about the chemistry of cineole 1 
biodegradation.  Two organisms had previously been independently isolated that could live on 
cineole 1 as their sole source of carbon and energy (18,20).  From an investigation of the 
oxidized cineole metabolites isolated from growth media, a consensus biodegradative pathway 
was proposed (Scheme 1), albeit proceeding via intermediates with different absolute 
stereochemistry in each of the two organisms.  Nothing was known about the enzymes involved 
in the proposed pathway, despite some early investigations (21).  Our results support the 
hypothesis that a P450 is responsible for the initial step in the biodegradation of cineole 1. 
  We isolated from the soil of a eucalypt forest a strain of C. braakii that could utilize 
cineole 1 for growth and energy.  C. braakii is a gram negative motile rod that is a common 
environmental organism and which has recently been reclassified from C. freundi (36).   P. flava 
and Rhodococcus, in which cineole 1 utilization had previously been found, are also common 
gram negative organisms.  Given the quantity of cineole 1 that is believed to be released into the 
environment by eucalypts, we were not surprised to find that a third genus of bacteria has 
developed the ability to grow on this compound.  The organism grew poorly on minimal medium 
in our hands when cultured on a large scale and although it grew well on nutrient rich media, 
such growth resulted in loss of its ability to utilize cineole 1.  This latter fact perhaps suggests 
that the genes responsible for cineole 1 metabolism are plasmid borne as has been shown for the 
P450s involved in camphor and terpineol utilization (10,37).  The difficulty in growing the 
organism, clearly meant that isolation of the gene encoding the cineole monooxygenase would be 
essential for its characterization.   
Initial approaches to isolating the P450 gene focused on its expected homology with other 
P450s, since this seemed to offer the most direct route to P450cin.  Homology based methodology 
in bacterial P450 systems is particularly difficult, however, since most of these proteins reside in 
sparsely populated families with only limited regional homology to one another.  However, with 
this in mind, a degenerate oligonucleotide was constructed based upon the conserved region that 
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includes the cysteine that ligates the heme iron and used to probe genomic DNA from C. braakii.  
A second protocol used this oligonucleotide in a genomic PCR with another degenerate primer 
based upon a conserved region seen in the redoxin reductase partners of P450cam and P450terp.  
The latter experiment was based on the hypothesis that the P450cin gene would be followed 
directly by those of its redox partners and that the first of these would encode a redoxin reductase 
as seen in the P450
cam
 and P450terp operons.  Both approaches were unsuccessful, in part due to the 
limited sensitivity of the degenerate oligonucleotides.  In addition, although the architecture of 
the P450cin operon was as expected, the proteins encoded constitute an entirely novel redox 
system for P450s with no homology to those found with other bacterial P450s. 
More protein specific information was thus required and this was obtained by isolating 
native P450cin from C. braakii.  Protein purification proved remarkably straightforward, with 
essentially homogenous protein obtained in three steps using a protocol based upon that 
published for P450
cam
 and P450BioI.  Protein sequence, obtained via trypsinolysis and peptide 
sequencing, was used to design degenerate PCR primers to either end of a large peptide fragment 
(Fig. 1).  A 92bp oligonucleotide probe for P450cin was then generated via genomic PCR.  This 
oligonucleotide was labeled with 32P by reaction with [γ-32P]-ATP in the presence of 
polynucleotide kinase but probing a series of restriction enzyme digests of C. braakii genomic 
DNA failed to yield useable results.  Believing that sensitivity was the source of our problems we 
chose to label the probe with [α-32P]-dCTP in the presence of terminal deoxynucleotidyl 
transferase (25).  TdT is known to transfer up to 30 nucleotides to the 3’ end of single stranded 
DNA, which results in an order of magnitude increase in the specific activity, and thus 
sensitivity, of the probe.  Utilization of [α-32P]-dCTP labeled oligonucleotide resulted in the 
eventual isolation of DNA fragments containing the P450cin gene. 
Sequencing of the isolated DNA revealed a putative P450cin operon that contained three 
open reading frames with overlapping start and stop codons (Fig. 2).  The first of these genes 
clearly encoded a P450, as seen by its strong similarity to a number of other bacterial P450s 
(Table 2).  The encoded protein was classified as CYP176A1 and trivially denoted P450cin.  
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Although most of the conserved residues found in P450s were also seen in P450
cin, there was one 
striking exception (Fig. 5).  Threonine 252 in P450
cam
 is located on the I-helix, a conserved 
structural feature of P450s, and is believed to hydrogen bond to a water molecule during the 
oxygen activation process and thus direct delivery of a proton to the distal oxygen in the iron-
dioxygen complex (38,39).  This specific delivery is believed to result in cleavage of the O-O 
bond to yield the active ferryl species; delivery of a proton to the proximal oxygen is thought to 
result in the dissociation of hydrogen peroxide (so called uncoupling).  Given the essential role of 
this residue in catalysis it is not surprising that a threonine or serine is seen in this position in 
essentially all known P450s.  An exception occurs in P450eryF (CYP107A1), in which it is 
replaced by an alanine; in this enzyme a hydroxyl group located on the substrate is believed 
responsible for the positioning of the required water molecule.  In P450cin, however, sequence 
alignments suggest that the threonine has been replaced with an asparagine.  Clearly, the amide 
functionality of the asparagine could serve to hydrogen bond to a water molecule and thus direct 
proton delivery and cleavage of the dioxygen bond.  However, this would be the first time that a 
hydroxyl group has not filled this role and further experimentation will be required to validate 
this hypothesis.   
[INSERT FIGURE 5 HERE] 
The two further genes discovered during the sequencing of the putative operon appear to 
encode potential redox partners for P450cin.  While this arrangement is identical to that seen in 
the P450
cam
 and P450terp operons, the identity of these redox partners is quite different.  In general 
there are two types of P450, as classified by their auxiliary electron transport partners.  In 
bacteria and mitochondria (Class I P450s) there are two proteins that mediate the transfer of 
electrons from the pyridine nucleotide to the P450, one is an FAD containing ferrodoxin 
reductase and the other is an iron sulfur protein, either 2Fe-2S or 3Fe-4S.  In eukaryotes (Class II 
P450s), there is generally a single flavoprotein, cytochrome P450 reductase that contains both an 
FAD and an FMN cofactor, which mediates P450 reduction.  Other, less common, arrangements 
also exist for electron transfer. P450
nor
 (40) accepts electrons directly from NADH while P450BM-3 
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(41), a bacterial P450, incorporates both a Class II like reductase and a P450 domain into a single 
polypeptide.  Class III P450s e.g. CYP74A do not require exogenous redox partners as they act 
upon peroxide containing substrates(42-44).  Analysis of the second gene in the P450cin operon 
revealed that it had strong homology with adrenoredoxin reductase, the ferrodoxin reductase that 
functions in the adrenal mitochondrial system (Table 2).  However, the third gene of the operon 
appeared to be a flavodoxin and not an iron sulfur containing protein as a BLAST search 
indicated that it was most homologous to the FMN domain of CPR (Table 2).  This suggests that 
P450cin utilizes a novel, natural redox system for electron transfer, which consists of an FAD 
dependent flavodoxin reductase and an FMN containing flavodoxin.  This system is intermediate 
between the classical Class I bacterial P450 that utilizes two proteins, but which includes one 
with an Fe-S cluster, and the Class II P450 which only employs a single protein but utilizes FAD 
and FMN cofactors.  While there is no precedent for this type of system occurring naturally, it 
has been reported that flavodoxins can act as “unnatural” redox partners for P450s.  Waterman 
has shown that the flavodoxin reductase and flavodoxin systems from both E. coli and Anabaena 
will serve as functional redox partners for a variety of (heterologous) mitochondrial P450s 
(33,45).  It should be noted that there is as yet no firm experimental evidence that links P450cin 
with the two proteins as its redox partners.  However, as mentioned, the arrangement of the genes 
within the operon is identical to that seen with both P450
cam
 and P450terp and their redox partners.   
It is interesting to note that while the biodegradative P450s such as P450
cam
, P450terp and 
P450cin occur in an operon closely associated with their redox partners, this is not the case for 
many other bacterial P450s uncovered by genome sequencing projects.  For example, in 
Mycobacterium tuberculosis of the approximately 20 P450s identified, at least 14 have no 
obvious operon associated redox partners.  Perhaps this implies that biodegradative P450s are 
necessarily organized into operons with their electron transfer proteins to ensure coordinated 
expression and efficient functioning.  Other bacterial P450s, which may not be required to 
operate as efficiently as biodegradative ones that supply the cell carbon and energy, may employ 
general redox partners such as cellular flavodoxins or ferrodoxins.   
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P450cin was heterologously expressed in E. coli at a level of approximately 2000 nmol/l 
of culture.  Purification, including a hydroxyapatite column (46) as a final polishing step, gave 
essentially homogenous protein (~1000 nmol/l) after three steps.  Its identity was confirmed by 
N-terminal sequencing and electrospray mass spectrometry, which also indicated that some N-
terminal processing (truncation of up to six amino acids) had occurred in a batch dependent 
manner.  However, spectral analysis of the protein (vide infra) revealed no effect of this 
inhomogeneity of the protein.  While catalytic activity remains to be explored, it is not expected 
that this variation will significantly alter its efficiency, given that the N-terminus is not 
implicated in either the mechanism of oxygen activation or the interaction with redox partners in 
any other bacterial P450 (47). 
We postulated that as P450
cin was believed to have a flavodoxin as a redox partner, it 
might utilize the endogenous E. coli flavodoxin/flavodoxin reductase system.  Waterman had 
reported that this system was responsible for the observed catalytic activity in a variety of 
heterologously expressed P450s (33,45).  Thus, we expressed P450
cin in the presence of cineole 1 
and careful GCMS analysis of the organic extracts of the growth medium revealed the presence 
of a metabolite tentatively identified as 2-hydroxycineole 2.  This compound was not produced 
when cineole 1 was added to the growth medium of E. coli not expressing P450
cin.  Whilst not 
conclusive, this result clearly demonstrates that P450
cin is capable of cineole 1 hydroxylation and 
strongly suggests that it is involved in its biodegradation. 
UV/visible analysis of the heterologously expressed P450cin revealed the typical 
characteristics of a bacterial P450 (Fig. 3).  Significantly, a spin state change of the heme iron 
from low spin to high spin was observed in the presence of cineole 1, typical of a bacterial P450 
in the presence of its substrate.  This, and the tight binding of cineole 1 to P450cin (KD = 0.7 µM) 
strongly support our hypothesis that the natural substrate for this enzyme is cineole 1, as it 
mirrors exactly the behavior of other terpene degrading P450s with their substrates, e.g., P450
cam
 
(5), P450terp (10), and P450lin (9).  These observations combined with our in vivo turnover results 
also provide the first real evidence that a P450 is involved in the biodegradation of cineole 1.  It 
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will be of interest to determine the way in which this strong, specific binding of cineole 1 is 
achieved as it presents little, if any, opportunity for H-bonding.  Such interactions are known to 
play an important role in the specific binding of other terpene substrates with their 
biodegradative P450 (48).  The oxygen in cineole 1 is present as a ditertiary ether, and as such 
unlikely to participate in any H-bonding.  It is hoped that crystallization trials currently underway 
may shed light on the specificity of this enzyme substrate interaction.   
Conclusion. A new bacterial P450 system has been isolated and the P450 cloned and 
over-expressed.  The high level of expression, as well as the ease of purification, encourage us in 
the belief that this P450 may serve as a useful model for P450s in general and bacterial P450s in 
particular.  It contains a number of unique features, such as an unusual asparagine substitution 
for a catalytically essential threonine, which should help to increase our fundamental 
understanding of P450 mechanism.  In addition, it appears that P450cin is the first known P450 to 
utilize a flavodoxin as its natural redox partner.  Experiments designed to further explore the 
catalytic activity and the interactions of P450cin with both its substrate and redox partners are 
currently in progress.   
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FIGURE CAPTIONS 
 
Figure  1 – PCR primer design based on tryptic peptide Fragment 1. (a) forward PCR primer (b) 
Fragment 1 (c) reverse PCR primer.  The restriction sites engineered into the 5’ ends of the 
primers are indicated.  Amino acid residues in parentheses are portions of the peptides not 
encoded by the oligonucleotide primers.  Degenerate nucleotide codes are shown in bold.  
F1PCR-F and F1PCR-R are 72- and 128-fold degenerate, respectively.   
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Figure 2 – Map of sequenced DNA from C. braakii. C1-C4 represent the DNA fragments 
isolated via southern hybridization experiments and cloned as pC1-pC4. Note only selected 
restriction sites are indicated. 
 
Figure 3 – Absorbance spectra of: •• oxidised P450cin; -----  oxidised P450cin plus cineole 1; •••••  
P450cin reduced by addition of sodium dithionite in the presence of cineole 1; 
• • •
  carbon 
monoxide complex of reduced P450
cin.  The oxidised substrate free form has absorbance maxima 
at 415 (ε = 150 mM-1 cm-1), 535, 568 nm.  Addition of 1,8-cineole 1 cases a shift in the Soret 
absorbance maximum to 392 (ε = 132 mM-1 cm-1) and 643 nm; the sodium dithionite reduced 
form has maxima at 411 (ε = 106 mM-1 cm-1) and 541 nm; and the reduced carbon monoxide 
complex form at 449 (ε = 125 mM-1 cm-1) and 547 nm. 
 
Figure 4 – UV/Visible difference spectra of P450
cin with increasing concentrations of cineole 1 
(0.25 to 16 µM) versus P450
cin alone.  Protein concentration was approximately 2 µM in 50 mM 
Tris-HCl, pH 7.4.  An isobestic point is seen at 404 nm.  These data were used to calculate a KD 
for the enzyme substrate complex by plotting (see Inset) absorbance difference between 392 and 
415nm versus cineole 1 concentration. 
 
Figure 5 – Clustal X alignment of bacterial P450s, showing the I-Helix and conserved heme 
binding domains. 
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TABLE I 
Sequences of Tryptic Peptides of Cytochrome P450cin 
Fragment  Sequence  Mol. Wt. Technique 
1 WAITHVENPEEGAEIFAELVAHAR 2690.4 Auto/MSa 
2 VWAITHVENPEEGAEIFAELVAHAR 2788.8 Auto/MS 
3 GEGDAATWLANEIPAR ND Auto 
a
 Auto – Automated Edman Sequencing; MS – mass spectrometry. 
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TABLE 2  
Sequence homology of the cinABC open reading frames 
Orf Protein Organism %Ia (%S)b Accession no.c ref. 
 
 
 
   
cinA CYP143  M. tuberculosis 33 (52) O53936 (49) 
 CYP107E1  (P450
mycG) M. griseorubida 32 (52) Q59523 (50) 
 CYP130  M. tuberculosis 30 (51) Q11062 (49) 
 CYP109  B. subtilis 30 (50) P27632 (51) 
 CYP113B1  (P450tylI)     S. fradiae 30 (49) Q59910 (52) 
 CYP107A1  (P450EryF)       S. erythraea 29 (45) Q00441 (53) 
 CYP101  (P450
cin) P. putida 27 (46) P00183 (54) 
 CYP107H  (P450BioI)      B. subtilis 27 (50) P53554 (55) 
 CYP101  (P450
cam
) P. putida 27 (46) P00183 (54) 
 CYP108  (P450terp) Pseudomonas sp. 25 (38) P33006 (10) 
  
 
   
 
 
 
   
cinB Adrenodoxin Reductase B. taurus 31 (47) P08165 (56) 
 Adrenodoxin Reductase S. fontinalis 31 (45) P82861 (57) 
 Adrenodoxin Reductase H. sapiens 31 (47) P22570 (58) 
 Ferredoxin-NAD(P+) Reductase M. tuberculosis 30 (46) Q10547 (49) 
      
 
 
 
   
cinC CPR (FMN-Binding Domain) H. sapiens 37 (56) P16435 (59) 
 Sulfite reductase flavoprotein S. aureus 35 (50) Q99R17 (60) 
 NADPH-CPR C. griseus 33 (51) Q60451 (61) 
 NADPH-CPR R. norvegicus 33 (51) P00388 (62) 
 Flavodoxin domain of P450BM-3 B. megaterium 31 (44) P14779 (41) 
 Flavodoxin D. salexigens 29 (49) P18086 (63) 
  
 
   
a
 Percent indentity 
b
 Percent similarity (indentity + substitutions with an amino acid with similar properties) 
c
 SWISS-PROT Accession Number 
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  (a) 
         EcoRI  
5’-ATAT GAATTC TGG GCN ATM ACN CAH GT-3’ 
  (b)         NH2-val-trp-ala-ile-tyr-his-val-(glu-asp-pro-glu-glu-gly- 
        ala-glu-ile-phe-ala-glu-lue)-val-ala-his-ala-arg-COOH 
  (c)                                 3’-CAN CGN GTR CGN KC CCATGG TATC-5’ 
                                     
                 BamHI
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 
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{FFFFFFFFI-HELIXFFFFFFFy                           HFL-HELIXFy                     
CYP101     245 LLLVGGLDTVVNFLSFSMEFLAKS 268……………346 VSHTTFGHGSHLCLGQHLAR 365 
CYP107A1   237 VLLLAGFEASVSLIGIGTYLLLTH 260……………339 RGHLSFGQGIHFCMGRPLAK 358 
CYP107E1   230 GLLVAGYESTTTQIADFVYLLMTR 253……………334 NQHLGFGHGVHHCLGAPLAR 353 
CYP107H     231 LLAIAGHETTVNLISNSVLCLLQH 254……………333 NPHLSFGHGHHVCLGSSLAR 352 
CYP108     263 AIATAGHDTTSSSSGGAIIGLSRN 286……………365 NRHLGFGWGAHMCLGQHLAK 384 
CYP109     237 LLLVAGNETTTNLIANAVRYLTED 260……………339 YPHLSFGFGIHFCLGAPLAR 358 
CYP111     241 LTLVGGNETTRNSISHTIVTLSQQ 264……………343 VQHVGFGSGQHVCVGSRLAE 362 
CYP113B1   252 LLLTAGHISSATLLGNLFLVLDEH 275……………354 NKHMSFGHGIHHCLGSFLAR 373 
CYP143     228 LLILAGLDTVTAAVGFSLLELARR 251……………330 HRHWGFGGGPHRCLGSHLAR 349 
P450cin     234 ILLLGGIDNTARFLSSVFWRLAWD 257……………335 NRHLSLGHGIHRCLGAHLIR 354 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 
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